This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45056544
rdf:type
wikibase:Item
schema:description
artigo científico bài báo khoa học article scientifique bilimsel makale 2004年學術文章 2004年の論文 scientific article published in September 2004 artikulong pang-agham 2004年学术文章 наукова стаття, опублікована у вересні 2004 مقالة علمية نشرت في سبتمبر 2004 επιστημονικό άρθρο সেপ্টেম্বর ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия artículo científico publicado en 2004 article científic scientific article published in September 2004 tieteellinen artikkeli სამეცნიერო სტატია artikel ilmiah 2004년 논문 2004年学术文章 2004年學術文章 article scientific 2004年學術文章 articol științific tudományos cikk 2004年学术文章 2004年学术文章 мақолаи илмӣ naučni članak vedecký článok 2004年学术文章 научни чланак artigo científico wissenschaftlicher Artikel artículu científicu научная статья vitenskapelig artikkel artykuł naukowy 2004年學術文章 scienca artikolo artigo científico videnskabelig artikel 2004年学术文章 2004 nî lūn-bûn vetenskaplig artikel מאמר מדעי artikull shkencor научни чланак teaduslik artikkel บทความทางวิทยาศาสตร์ articolo scientifico scientific article published in September 2004 2004年學術文章 wetenschappelijk artikel vědecký článek vitskapeleg artikkel
p:P577
wds:Q45056544-2CA399A3-DED2-42FC-BFC3-9639C2119BED
wdt:P577
2004-09-01T00:00:00Z
p:P407
wds:Q45056544-4285D967-D2F2-4F17-8AF5-D888A62E12F2
wdt:P407
wd:Q1860
p:P2093
wds:Q45056544-4ABF7F91-C7A8-476B-9FFA-A1BCFB2789C4 wds:Q45056544-78CBAF1B-950B-4E3E-BFE4-5426EFD166B7 wds:Q45056544-CE1B6FE7-D104-4B02-97BB-1B7A3EACBD9D wds:Q45056544-D58BBE10-D529-49F8-AF4B-0FC4A535969C wds:Q45056544-BB759FFF-7D33-4079-925F-C4D7FD408B3D wds:Q45056544-DCAB4501-1C17-4D87-8355-2D0DD2921D64 wds:Q45056544-FC9E55E3-769F-40BE-B59E-C618E1FD59FF wds:Q45056544-D60D0734-CC02-4371-A0C9-2DF5E17BC557
wdt:P2093
Steven L Maskin Howard M Proskin Teresa Micuda Roger Vogel Bruce Anderson Edward J Holland Stephen P Bartels Stephen C Pflugfelder
rdfs:label
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance
skos:prefLabel
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance
schema:name
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance
p:P50
wds:Q45056544-6955AEC7-00BC-4DB6-824F-5A9D9BE92FF8 wds:Q45056544-1F81C430-BCD1-46EA-9CCB-9C5EB917D886
wdt:P50
wd:Q44473623 wd:Q90193691
p:P1476
wds:Q45056544-D992492B-882B-483C-A0FA-75AEF8941653
wdt:P1476
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance
p:P304
wds:Q45056544-54311A2A-E894-4DC3-9031-3B206C0A543C
wdt:P304
444-457
p:P31
wds:Q45056544-1C7B2426-ABE7-428E-B6C0-0A5AE8F8DEEA
wdt:P31
wd:Q13442814
p:P921
wds:Q45056544-93EF3CB7-2F33-4B4A-8147-76E77D99DF4E wds:Q45056544-3072A0AB-4716-4CF6-80E3-6A0FA847C70A wds:Q45056544-C3C3E735-5301-474E-89C5-ACFFCFFB5814
wdt:P921
wd:Q181600 wd:Q1162694 wd:Q269829
p:P698
wds:Q45056544-264B0254-33AA-46E7-B98F-B1AB61AFBC7F
wdtn:P698
n9:15364229
wdt:P698
15364229
p:P1433
wds:Q45056544-2E0CEF4B-098C-436D-AC2C-7E66D5BE1955
wdt:P1433
wd:Q4744258
p:P433
wds:Q45056544-47020EFC-267A-4EEF-B8ED-9249F7EB370A
p:P478
wds:Q45056544-5894A97D-1DD8-448D-A9A0-D8CB51CFBD13
wdt:P433
3
wdt:P478
138
p:P356
wds:Q45056544-2B5B74E2-617A-4BCA-80CF-0A2B7213B3CC
wdtn:P356
n8:J.AJO.2004.04.052
wdt:P356
10.1016/J.AJO.2004.04.052
p:P8608
wds:Q45056544-4EF1471D-7AFF-44F8-8D11-5FA2D7470820
wdt:P8608
release_ksr7lx742rgkxei3fvuy52d3zm